新生血管性AMD抗VEGF治疗后长期视力良好眼的形态学特征
该回顾性观察研究纳入175例新生血管性AMD患者共203眼,抗VEGF治疗随访平均7.84±1.70年。结果显示视力良好组黄斑中心凹下最大PED厚度(97.92 μm)显著大于视力中等组(86.25 μm)和视力差组(13.11 μm),而最大SHRM厚度(9.35 μm)显著小于视力中等组(64.37 μm)和视力差组(149.46 μm)(均p<0.001)。视力良好组外层视网膜各带连续性也更好。
要点
- 较厚的PED和较薄的SHRM与新生血管性AMD抗VEGF治疗后长期较好视力相关。
- 视力良好组外层视网膜带(ELM、EZ、RPE)连续性优于中等和差视力组(均p<0.001)。
- 若经前瞻性研究验证,这些形态学指标可能有助于设计新生血管性AMD治疗的最佳解剖学终点。
核心结论
- 在新生血管性AMD长期抗VEGF治疗后,较厚的PED和较薄的SHRM与较好视力相关。
研究设计与样本
- 回顾性观察研究纳入175例新生血管性AMD患者共203眼,抗VEGF治疗起始后随访>5年。
主要发现
- 黄斑中心凹下最大PED厚度在视力差组为13.11 μm,显著低于视力中等组86.25 μm和视力良好组97.92 μm(p<0.001)。
- 黄斑中心凹下最大SHRM厚度在视力差组为149.46 μm,显著高于视力中等组64.37 μm,后者又显著高于视力良好组9.35 μm(均p<0.001)。
- 视力良好组外层视网膜带(ELM、EZ、RPE)连续性优于其他两组(均p<0.001)。
临床怎么用
- 临床评估新生血管性AMD抗VEGF治疗预后时可关注PED厚度、SHRM厚度及外层视网膜带完整性。
局限性
- 研究为回顾性观察设计,结论需前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To analyse the morphological characteristics of eyes with neovascular age-related macular degeneration (AMD) with good long-term visual acuity after anti-VEGF (vascular endothelial growth factor) therapy. METHODS: Retrospective, observational study of 175 patients with neovascular AMD with >5 years of follow-up after initiating anti-VEGF therapy. Spectral-domain optical coherence tomography images were assessed for thickness of pigment epithelial detachment (PED), subretinal hyper-reflective material (SHRM), subretinal fluid and subfoveal choroidal, as well as the integrity of the outer retinal bands. RESULTS: The final analysis cohort included 203 eyes (175 patients) followed for a mean of 7.84±1.70 years (range: 5-11). The maximum PED thickness in the foveal central subfield (FCS) was significantly lower (p<0.001) in the poor vision group (13.11 μm) compared with the intermediate (86.25 μm) or good (97.92 μm) vision groups, respectively. In contrast, the maximum thickness of SHRM in the FCS was significantly thicker (p<0.001) in eyes with poor vision (149.46 μm) compared with eyes with intermediate vision (64.37 μm) which in turn were significantly thicker (p<0.001) than eyes with good vision (9.35 μm). The good vision group also had better continuity of all outer retinal bands (external limiting membrane, ellipsoid zone, and retinal pigment epithelium) compared with the other two groups (all p<0.001). CONCLUSION: A thicker PED and thinner SHRM were correlated with better vision in eyes with neovascular AMD following long-term anti-VEGF therapy. If replicated in future prospective studies, these findings may have implications for design of optimal anatomic endpoints for neovascular AMD treatment.
引用
- Fang M, Chanwimol K, Maram J, et al. Morphological characteristics of eyes with neovascular age-related macular degeneration and good long-term visual outcomes after anti-VEGF therapy. Br J Ophthalmol. 2021. PMID: 34561217. doi:10.1136/bjophthalmol-2021-319602
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。